Clinical Trials Sponsored by Abbott Products

Total 3666 results

Abbott

Completed

Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

Healthy

United States
Abbott

Completed

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).

Lymphoma | Chronic Lymphocytic Leukemia | Solid Tumors

United States
Abbott

Completed

A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid

Healthy

United States
Abbott

Terminated

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

HIV | Tuberculosis

United States
Abbott

Completed

A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD | Attention-Deficit/Hyperactivity Disorder

United States
Abbott

Completed

A Safety and Tolerability Study of ABT-126 in Elderly

Alzheimer's Disease

United States
Abbott

Completed

Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072

Hepatitis C

United States
Abbott

Completed

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C

HCV Infection

United States
Abbott

Completed

Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation

Hepatitis C

United States
Abbott

Completed

A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

Pharmacokinetics

United States
Abbott

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

HCV Infection

United States
Abbott

Completed

Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

HCV Infection

United States
Abbott

Completed

Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers

Healthy

United States
Abbott

Completed

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS) (ACCESS)

Crohn's Disease

United States
Abbott

Completed

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Dyslipidemia

United States
Abbott

Completed

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Abbott

Completed

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

HIV Infections

United States
Abbott

Completed

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

HIV Infections

United States
Abbott

Completed

A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients

HIV Infections

United States
Abbott

Completed

A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)

HIV Infections

United States
Abbott

Completed

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

HIV Infections | Sarcoma, Kaposi

Australia
Abbott

Completed

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

HIV Infections

United States, Canada, Puerto Rico, Switzerland, France, Germany, United Kingdom, Australia, Brazil, Austria, Denmark, Poland, South Africa, Spain
Abbott

Completed

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis (ReAct)

Rheumatoid Arthritis
Abbott

Completed

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL) (TRAIL)

Hypertension
Abbott

Completed

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis (CHAMPION)

Psoriasis

United States
Abbott

Completed

A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) (BENEDICT)

Hypertension | Diabetes
Abbott

Completed

Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) (STAR)

Hypertension | Metabolic Syndrome
Abbott

Completed

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Obesity

United States
Abbott

Completed

Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Hypertension

United States
Abbott

Completed

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Leiomyoma
Abbott

Completed

A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women

Postmenopause
Abbott

Completed

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Leiomyoma | Uterine Fibroids
Abbott

Completed

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

Metrorrhagia | Leiomyoma | Menorrhagia
Abbott

Completed

A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women

Amenorrhea | Postmenopause
Abbott

Completed

A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

Metrorrhagia | Leiomyoma | Uterine Fibroids | Menorrhagia | Fibroid Uterus
Abbott

Completed

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives (HOS)

Hypertension | Obesity
Abbott

Completed

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

Obesity
Abbott

Completed

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients (MONARK)

HIV Infection
Abbott

Approved for marketing

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis (CanAct)

Rheumatoid Arthritis
Abbott

Completed

Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

Rheumatoid Arthritis

Taiwan
Abbott

Approved for marketing

Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab (PROWD)

Rheumatoid Arthritis
Abbott

Completed

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Abbott

Completed

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

Arthritis | Psoriatic
Abbott

Completed

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media

Acute Otitis Media

United States
Abbott

Completed

Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

A Long Term Safety Study With Atrasentan

Adenocarcinoma | Prostate Cancer

Canada, United States, France, Netherlands, United Kingdom
Abbott

Completed

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Abbott

Withdrawn

A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

Asthma
Abbott

Completed

A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers

Drug Interactions

Canada
Abbott

Completed

A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections

Mild to Moderate Uncomplicated Skin and Skin Structure Infections

3

Subscribe